Price T Rowe Associates Inc Embecta Corp. Transaction History

Price T Rowe Associates Inc

$935 Billion
Q3 2025

A detailed history of Price T Rowe Associates Inc transactions in Embecta Corp. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 68,081 shares of EMBC stock, worth $990,578. This represents 0.0% of its overall portfolio holdings.

Number of Shares

68,081

Previous 65,128 4.53%

Holding current value

$990,578

Previous $632,000 52.06%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$9.58 - $15.31 $28,289 - $45,210	2,953 Added 4.53%	68,081 $961,000
Q2 2025 Aug 14, 2025	BUY	$9.28 - $13.3 $30,688 - $43,983	3,307 Added 5.35%	65,128 $632,000
Q1 2025 May 14, 2025	BUY	$12.28 - $20.93 $28,047 - $47,804	2,284 Added 3.84%	61,821 $789,000
Q4 2024 Feb 14, 2025	BUY	$12.51 - $20.83 $47,437 - $78,987	3,792 Added 6.8%	59,537 $1.23 Million
Q3 2024 Nov 14, 2024	BUY	$11.46 - $16.56 $94,957 - $137,216	8,286 Added 17.46%	55,745 $787,000

Q2 2024 Aug 14, 2024	BUY	$10.13 - $14.6 $18,487 - $26,645	1,825 Added 4.0%	47,459 $594,000
Q1 2024 May 15, 2024	SELL	$12.35 - $19.33 $1.33 Million - $2.08 Million	-107,604 Reduced 70.22%	45,634 $606,000
Q4 2023 Feb 14, 2024	SELL	$12.87 - $19.09 $2.59 Million - $3.84 Million	-201,318 Reduced 56.78%	153,238 $2.9 Million
Q3 2023 Nov 14, 2023	SELL	$15.0 - $22.17 $753,135 - $1.11 Million	-50,209 Reduced 12.4%	354,556 $5.34 Million
Q2 2023 Aug 14, 2023	BUY	$21.6 - $30.69 $209,865 - $298,184	9,716 Added 2.46%	404,765 $8.74 Million
Q1 2023 May 15, 2023	BUY	$23.07 - $32.77 $2.39 Million - $3.39 Million	103,551 Added 35.52%	395,049 $11.1 Million
Q4 2022 Feb 14, 2023	BUY	$25.29 - $35.48 $6.98 Million - $9.79 Million	276,020 Added 1783.31%	291,498 $7.37 Million
Q3 2022 Nov 14, 2022	SELL	$24.0 - $33.42 $75 Million - $104 Million	-3,125,788 Reduced 99.51%	15,478 $446,000
Q2 2022 Aug 15, 2022	BUY	$24.78 - $33.36 $17.2 Million - $23.1 Million	692,770 Added 28.29%	3,141,266 $79.5 Million
Q1 2022 May 16, 2022	BUY	$33.33 - $47.0 $81.6 Million - $115 Million	2,448,496 New	2,448,496 $81.6 Million

Others Institutions Holding EMBC

# of Institutions

411

Shares Held

56.8M

Call Options Held

345K

Put Options Held

68.7K

View Full List

About Embecta Corp.

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $842M
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

More about EMBC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Embecta Corp. Transaction History